Liquidia Corporation (LQDA)

NCM – Real Time Price. Currency in USD

56.60

+3.47 (6.53%)

At close: May 12, 2026, 4:00 PM EDT

55.92

-0.68 (-1.20%)

Pre-market: May 13, 2026, 4:43 AM EDT

08.05.2026

Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG

Low beta screen highlights LQDA, CBOE, VLO and FANG as Middle East tensions keep U.S. stocks volatile, and investors favor steadier movers.

06.05.2026

Liquidia Corporation to Participate in Upcoming Investor Conferences

MORRISVILLE, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced it will participate in upcoming investor conferences.

06.05.2026

New Strong Buy Stocks for May 6th

INTT, EOG, UVE, LQDA and UMBF have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2026.

04.05.2026

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

MORRISVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its first quarter 2026 financial results on Monday, May 11, 2026.

27.04.2026

This Drug Stock Nears A Buy Point, With Profit Set To Explode

This drug stock is testing a moving average in a base. This biopharma name has a patented technology to administer its drug.

19.04.2026

Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million

53,300 shares were sold indirectly for a transaction value of ~$2.14 million across April 14, 2026, to April 16, 2026, at a weighted average price of around $40.21 per share. Direct and indirect holdings are now at 1,137,599 and 1,441,934 shares, respectively.

05.04.2026

Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?

Director Stephen Bloch sold 70,234 shares indirectly through Canaan VIII, L.P. in open-market transactions on March 26 and March 27, 2026.

Videos

No Data

There is no data to display

Press releases

05.03.2026

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

MORRISVILLE, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today reported financial results for the full year ended December 31, 2025. The company will also host a webcast at 8:30 a.m. ET on March 5, 2026, to discuss its financial results and provide a corporate update.

12.08.2025

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

MORRISVILLE, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced its financial results for the second quarter ended June 30, 2025. The company will also host a webcast at 8:30 a.m. Eastern Time on August 12, 2025, to review financial performance and provide a corporate update.

Liquidia Corporation (LQDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Liquidia Corporation (LQDA)

Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG

Liquidia Corporation to Participate in Upcoming Investor Conferences

New Strong Buy Stocks for May 6th

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

This Drug Stock Nears A Buy Point, With Profit Set To Explode

Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million

Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?

Videos

No Data

Press releases

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG

Liquidia Corporation to Participate in Upcoming Investor Conferences

New Strong Buy Stocks for May 6th

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

This Drug Stock Nears A Buy Point, With Profit Set To Explode

Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million

Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?

Videos

No Data

Press releases

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Search stocks

Liquidia Corporation (LQDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Liquidia Corporation (LQDA)

Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG

Liquidia Corporation to Participate in Upcoming Investor Conferences

New Strong Buy Stocks for May 6th

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

This Drug Stock Nears A Buy Point, With Profit Set To Explode

Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million

Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?

Videos

No Data

Press releases

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG

Liquidia Corporation to Participate in Upcoming Investor Conferences

New Strong Buy Stocks for May 6th

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

This Drug Stock Nears A Buy Point, With Profit Set To Explode

Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million

Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?

Videos

No Data

Press releases

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update